Biotech NewsCytomX (CTMX) Boosts Cash to $158.1M After $100M Raise BioTech Health XSeptember 15, 2025 CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biotechnology company dedicated to transforming the treatment of cancer through its… 0 Shares 0 0 0 0 0 0 0